Active Ingredient History

  • Now
Aplaviroc is a CCR5 entry inhibitor that belongs to a class of 2,5-diketopiperazines developed for the treatment of HIV infection. It was developed by GlaxoSmithKline.   Wikipedia

  • SMILES: CCCCN1C(=O)[C@H](NC(=O)C12CCN(Cc3ccc(Oc4ccc(cc4)C(=O)O)cc3)CC2)[C@H](O)C5CCCCC5
  • Mol. Mass: 577.72
  • ALogP: 4.58
  • ChEMBL Molecules:
More Chemistry
4-((4-(((3r)-1-butyl-3-((r)-cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro(5.5)undec-9-yl)methyl)phenyl)oxy)benzoic acid hydrochloride | aplaviroc | aplaviroc hcl | aplaviroc hydrochloride | benzoic acid, 4-(4-(((3r)-1-butyl-3-((r)-cyclohexylhydroxymethyl)-2,5-dioxo-1,4,9- triazaspiro(55)undec-9-yl)methyl)phenoxy)- | gw873140 | gw873140a


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue